[144] Hinge Health, Inc. SEC Filing
HNGE insider Kristina Leslie has filed a Form 144 notice covering the proposed sale of 1,250 shares of HNGE common stock through Morgan Stanley Smith Barney LLC on the NYSE. The shares are valued at an aggregate market value of $57,106.00 based on the filing and are part of a class with 37,919,155 shares outstanding.
The filing shows these shares were acquired as restricted stock from the issuer, with 688 shares acquired on 04/01/2025 and 562 shares on 01/01/2025. Over the prior three months, Leslie reported additional open-market sales of HNGE common stock, including 3,813 shares sold on 11/19/2025 for gross proceeds of $166,257.86 and 2,187 shares sold on 11/18/2025 for $88,476.40.
- None.
- None.
FAQ
What does the HNGE Form 144 filing disclose about planned share sales?
The Form 144 filing discloses that Kristina Leslie intends to sell up to 1,250 shares of HNGE common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $57,106.00.
How many HNGE shares did the insider recently sell before this Form 144?
Over the past three months, Kristina Leslie reported selling 3,813 shares of HNGE common stock on 11/19/2025 for $166,257.86 and 2,187 shares on 11/18/2025 for $88,476.40.
How were the HNGE shares in the Form 144 acquired?
The 1,250 shares covered by the Form 144 were acquired as restricted stock from the issuer, with 688 shares acquired on 04/01/2025 and 562 shares on 01/01/2025.
What is the reported number of HNGE shares outstanding in this filing?
The filing reports that HNGE common stock has 37,919,155 shares outstanding, providing context for the relative size of the 1,250-share planned sale.
Which broker and exchange are involved in the HNGE Form 144 share sale?
The planned sale of 1,250 HNGE common shares is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE.
What assurance does the insider provide about information on HNGE?
By signing the notice, the insider represents that they do not know of any material adverse information about HNGE’s current or prospective operations that has not been publicly disclosed.